An Observational Study to Evaluate the Safety and Efficacy of Cetuximab in Combination With Platinum-based Chemotherapy in the First-line Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
This study is currently recruiting participants.
Verified February 2013 by Merck KGaA
Study NCT01142869
Information provided by Merck KGaA
First Received on June 10, 2010.
Last Updated on February 22, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
